SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001128732-19-000028
Filing Date
2019-10-04
Accepted
2019-10-04 19:03:56
Documents
1
Period of Report
2016-12-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 3105
  Complete submission text file 0001128732-19-000028.txt   4749
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 731 PLACE DE L'EEAU VIVE LAVAL A8 H7Y 2E1
Business Address
MERZOUKI ABDERRAZZAK (Reporting) CIK: 0001636418 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-52898 | Film No.: 191139444